About Vivosight
Vivosight is a company based in Maidstone (United Kingdom) founded in 2006. Vivosight has raised $8.9 million across 4 funding rounds from investors including Smith & Nephew, Octopus Ventures and Kent County Council. The company has 8 employees as of September 30, 2024. Vivosight operates in a competitive market with competitors including SpectraWAVE, NinePoint Medical, DermaSensor, MedLumics and SciBase, among others.
- Headquarter Maidstone, United Kingdom
- Employees 8 as on 30 Sep, 2024
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Michelson Diagnostics Ltd
- Date of Incorporation 07 Mar, 2006
- Jurisdiction NOTTINGHAM, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$8.9 M (USD)
in 4 rounds
-
Latest Funding Round
$3.37 M (USD), Series B
Feb 09, 2015
-
Investors
Smith & Nephew
& 4 more
-
Employee Count
8
as on Sep 30, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Vivosight
Unlock access to complete
Unlock access to complete
Funding Insights of Vivosight
Vivosight has successfully raised a total of $8.9M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $3.37 million completed in February 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Vivosight
Vivosight has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Smith & Nephew, Octopus Ventures and Kent County Council.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investment and support for founders in technology and health sectors.
|
Locked | Locked | Locked | |
|
Investment solutions are provided by Catapult Ventures for growth.
|
Locked | Locked | Locked | |
|
Manufacturer of knee, hip and shoulder joint replacements
|
Locked | Locked | Locked |
Investor details for Vivosight
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Vivosight
Investment portfolio details for Vivosight
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Vivosight
Detailed financials for Vivosight
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vivosight Comparisons
Peer comparison for Vivosight
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Vivosight
Vivosight operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SpectraWAVE, NinePoint Medical, DermaSensor, MedLumics and SciBase, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Photonic imaging diagnostics for cardiovascular disease treatment are provided.
|
|
| Locked | Locked | Locked |
Optical coherence tomography systems for tissue microstructure imaging are developed.
|
|
| Locked | Locked | Locked |
Handheld diagnostic device for skin cancer lesions is developed.
|
|
| Locked | Locked | Locked |
Biological tissue imaging is developed using optical coherence tomography.
|
|
| Locked | Locked | Locked |
Point-of-care device for malignant melanoma detection is provided.
|
|
| Locked | Locked | Locked |
Image-based intra-body navigation technology for medical diagnostics is developed.
|
Detailed competitors of Vivosight
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vivosight
Complete news archive for Vivosight
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vivosight
Vivosight was founded in 2006 and raised its 1st funding round 4 years after it was founded.
Vivosight is headquartered in Maidstone, United Kingdom.
Jonathan Denis Holmes is the current CEO of Vivosight.
Vivosight is a funded company, having raised a total of $8.9M across 4 funding rounds to date.
As of Sep 30, 2024, the latest employee count at Vivosight is 8.
Founded in 2006 in Maidstone, United Kingdom, optical coherence tomography diagnostic devices for dermatology are provided by the company. Medical imaging technology is developed to produce detailed sub-surface images of skin. Non-invasive diagnosis and monitoring of skin conditions, including non-melanoma skin cancer, are facilitated. Lesion information beyond clinical or dermoscopic visibility is generated, supporting treatment decisions at initial appointments and during follow-ups.
Vivosight's top competitors include DermaSensor, NinePoint Medical and SciBase.
Vivosight has 5 investors. Key investors include Smith & Nephew, Octopus Ventures, Kent County Council, London Business Angels, and Catapult Ventures.